Concepedia

Author

Michael Löw

Monash UniversityORCID

Also Known As

M. Low, M. Löw, M. S. Y. Low, Michael Low, Michael Löw, Michael S. Low, Michael S. Y. Low, Michael S.Y. Low, Michael SY Low, Michael Sze Yuan Low

80

Publications

1.4K

Citations

16

H-Index

28

Concepts

All Affiliations

Monash UniversityWalter and Eliza Hall Institute of Medical ResearchMonash HealthThe University of MelbourneThe Royal Melbourne Hospital
ML

About

Michael Löw is an author at Monash University specializing in medicine, hematology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

285

2

Cell Biology

2

2

76

3

Engineering

1

1

80

4

Health Sciences

1

1

113

5

Biomedical Engineering

1

1

80

Michael Löw

×

13

Publications

727

Citations

12

H-Index

YearCitations

Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study

Meletios Α. Dimopoulos, Vânia Hungria, Atanas Radinoff,

The Lancet Haematology

2023

113

Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre

Thanh T. Nguyen, Trevor Gin, Kathy Nicholls,

Clinical and Experimental Ophthalmology

2005

100

IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos

Pasquale L. Fedele, Simon N. Willis, Yang Liao,

Blood

2018

87

Hemodynamics in rigid and distensible saccular aneurysms: A numerical study of pulsatile flow characteristics

Michael Löw, Karl Perktold, R. Raunig

Biorheology

1993

80

IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis

Michael Löw, Erica J. Brodie, Pasquale L. Fedele,

Cell Reports

2019

75

Neurology of Fabry disease

Michael Löw, Kathy Nicholls, Niall Tubridy,

Internal Medicine Journal

2007

60

An Erg-driven transcriptional program controls B cell lymphopoiesis

Ashley P. Ng, Hannah D. Coughlan, Soroor Hediyeh-zadeh,

Nature Communications

2020

52

Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains

Denise Lee, Anna Kalff, Michael Löw,

British Journal of Haematology

2013

45

Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells

Charis E. Teh, Jianan Gong, David Segal,

Cell Death and Differentiation

2020

42

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival

Pasquale L. Fedele, Yang Liao, Jianan Gong,

Leukemia

2020

34

Page 1